Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Beijing Immunochina Medical Science & Technology Co., Ltd. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
melanomanon-small-cell-lung-cancer
melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 908327
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.